Competition between microfluidic- and array-based technologies that can detect the presence of biological and chemical threats has increased in recent months.

Agilent has released a microfluidic-based pathogen detector, while rival companies plan this year on providing government sponsors with array-based threat-detecting prototypes.

The firm has been busy recently marketing its automated lab-on-chip platform [ALP] 5100 bioanalyzer — most prominently to the US Departments of Homeland Security and Defense — as a rapid pathogen-detection system.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.